Warnings -- COLUMNS-Drugs & Supplements -- January 2004
January 21, 2004
UK Health Authorities to Conduct Study on Antidepressant-Suicide Link
LONDON - Britain's Medicines and Healthcare Products Regulatory Agency (MHRA) recently announced that it was initiating a study aimed at investigating the risk of suicide in patients taking antidepressants.
According to the agency's Jan. 6 statement, the study would estimate the risk of suicide, suicidal thoughts, non-fatal overdose, and self-laceration in patients taking selective serotonin reuptake inhibitors (SSRIs), such as Paxil, Prozac and Zoloft, and older antidepressants known as tricyclic antidepressants (TCA).
The study's protocol stated that that relative risk of suicide will be calculated for SSRI and TCA therapy …
UPCOMING CONFERENCES
HarrisMartin's Mass Tort Settlements Conference - Sponsored by Milestone
June 25, 2025 - Buffalo, NY
The Westin Buffalo
HarrisMartin's Webinar Series: Water Contamination Litigation Presented by EisnerAmper
May 06, 2025